Charles Catton

Princess Margaret Cancer Centre

Papers

1

Total Citations

4

H-Index

1

About

Charles Catton is a distinguished radiation oncologist whose research has significantly advanced the treatment of prostate cancer, particularly in the integration of surgery and radiotherapy. His key contributions focus on optimizing post-prostatectomy radiation planning, where he has investigated how surgical approaches—such as transperitoneal laparoscopic prostatectomy—affect the spatial distribution of organs at risk, like the small bowel. In his notable 2009 study, Catton demonstrated that transperitoneal surgery does not increase small bowel volume within the pelvic radiotherapy target, a finding that reassures clinicians and refines treatment protocols. While this specific paper has garnered modest citations, Catton’s broader impact is evident in his collaborative work on prostate cancer outcomes, toxicity reduction, and image-guided radiation techniques. His research has helped shape evidence-based guidelines, improving the precision and safety of postoperative radiotherapy. Catton’s work is widely recognized within the radiation oncology community, and he remains an influential figure in bridging surgical and radiotherapeutic disciplines to enhance patient care.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Transperitoneal Laparoscopic Prostatectomy Does Not Increase Small Bowel Within the Target Volume for Postoperative Radiotherapy
4 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Princess Margaret Cancer Centre

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago